Contact
Please use this form to send email to PR contact of this press release:
(OTC: CATV) Reports Nearly $500K in Q4 Revenue, eliminates $830K in Debt, and Appoints CEO to Lead Bold Transformation
TO:
Michael Feldenkrais
Category V Biotech, Inc.
+1 310-800-6161